市场调查报告书

全球痔瘘治疗市场:2020-2026

Global Anal Fistula Therapeutics Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品编码 949663
出版日期 内容资讯 英文
商品交期: 2-3个工作天内
价格
全球痔瘘治疗市场:2020-2026 Global Anal Fistula Therapeutics Market 2020-2026
出版日期: 2020年06月27日内容资讯: 英文
简介

在预测期内,估计全球痔瘘治疗市场将显著增长。 IBD的高流行主要是推动市场增长。新的非手术选择有望为市场增长提供机会。纤维蛋白胶和alloficell(darvadstrocel)是市场上用于治疗痔瘘的非手术选择。当患者处于全身麻醉状态时,纤维蛋白胶可以使外科医生将胶水注入瘘管。这种粘合剂可密封瘘管并帮助其愈合。它通常不如具有简单瘘管的瘘管切口有效。

结果可能不会持续很长时间。但是,穿过肛门括约肌的瘘管可能是瘘管的替代方法,因为它不需要切割。如果瘘管对至少一种传统或生物疗法的反应较差,Alloficell(darvadstrocel)是患有无效/轻度活动性管腔克罗恩病的成年患者的复合体是第一个治疗大肛周瘘管的干细胞疗法。预计将来会引入更多非手术选择,这可能会为市场增长提供重要机会。

在地理上,由于IBD的流行和该地区相当大的健康意识,北美在2019年占据了最大的市场占有率。根据疾病控制与预防中心(CDC)的数据,2015年,美国有近1.3%(300万)成年人被诊断出患有IBD(溃疡性结肠炎或克罗恩氏病)。炎症或受伤器官是IBD的常见并发症,在克罗恩病中比溃疡性结肠炎更常见,它更容易形成瘘管。因此,IBD的日益普及为市场增长做出了贡献。

该报告调查了全球痔瘘治疗市场,并提供了按治疗,应用,最终用户和地区划分的市场概况以及趋势,以及进入该市场的公司的概况。

内容

第1章报告概述

第2章市场概述和见解

  • 调查范围
  • 分析师见解和当前市场趋势
  • 规则和规定

第3章竞争情况

  • 公司占有率分析
  • 主要策略分析
  • 主要公司分析
    • Medtronic plc
    • Karl Storz SE&Co. KG
    • Cook Group Inc.
    • Takeda Pharmaceutical Co. Ltd.
    • Signum Surgical Ltd.

第4章市场决定因素

  • 动机
  • 抑制因子
  • 市场机会

第5章市场细分

  • 全球肛门瘘治疗市场(按治疗)
    • 外科
    • 非手术
  • 全球痔瘘治疗应用市场
    • 括约肌筋间痔瘘
    • 括约肌筋痔瘘
    • 括约肌痔瘘
    • 其他
  • 最终用户的全球痔瘘治疗市场
    • 医院
    • 门诊手术中心
    • 其他

第6章区域分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 其他
  • 其他地区

第7章公司简介

  • Medtronic plc
  • Cook Group Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Karl Storz SE & Co. KG
  • Biolitec AG
  • Pfizer Inc.
  • Becton, Dickinson and Co.
  • GEM S.r.l.
  • TiGenix NV
  • W. L. Gore & Associates, Inc.
  • AstraZeneca plc
  • Agency for Medical Innovations (A.M.I.) GmbH
  • Signum Surgical Ltd.
  • Novartis International AG
  • Assembly Biosciences, Inc.
  • Ovesco Endoscopy AG
目录
Product Code: OMR2021982

Global Anal Fistula Therapeutics Market Size, Share & Trends Analysis Report, By Treatment (Surgical and Non-Surgical), By Application (Intersphincteric Fistula, Transsphincteric Fistula, Suprasphincteric Fistula, and Others), By End-User (Hospitals, Ambulatory Surgical Centers, and Others) and Forecast, 2020-2026

The global anal fistula therapeutics market is estimated to grow significantly during the forecast period. The significant prevalence of IBD is primarily driving the growth of the market. Emerging non-surgical alternatives is expected to offer an opportunity for market growth. Fibrin glue and Alofisel (darvadstrocel) are the non-surgical alternatives available in the market for the treatment of anal fistula. Fibrin glue involves injecting a glue by the surgeon into the fistula when the patient is under general anaesthetic. This glue enables to seal the fistula and supports it to heal. It is usually less effective compared to fistulotomy for simple fistulas.

Its results may not last for a longer period; however, it may be a helpful alternative for fistulas that pass through the anal sphincter muscles as the cut is not required there. Alofisel (darvadstrocel) is the first stem cell therapy to treat complex perianal fistulas in adult patients suffering from nonactive/mildly active luminal Crohn's disease when fistulas have shown an insufficient response to at least one traditional or biologic therapy. More non-surgical alternatives are expected to be introduced in the future, which will likely present a significant opportunity for the growth of the market.

Geographically, in 2019, North America held the largest share in the market owing to the rising prevalence of IBD and considerable health awareness in the region. As per the Centers for Disease Control and Prevention (CDC), in 2015, nearly 1.3% of the US adults (3 million) were reported being diagnosed with IBD (either ulcerative colitis or Crohn's disease). Increased chances of developing fistulas occur when the organ becomes inflamed or injured, which is a common complication of IBD, found most frequently in Crohn's disease than ulcerative colitis. Therefore, the rising prevalence of IBD is contributing to the growth of the market.

Some key players in the market include Medtronic plc, Karl Storz SE & Co. KG, Cook Group Inc., Takeda Pharmaceutical Co. Ltd., and Signum Surgical Ltd. Medtronic offers Permacol collagen paste, which is a minimally invasive treatment for anal fistula. It is made of porcine dermal, acellular collagen suspended in saline. It may be utilized as a single treatment alternative or in combination with other treatment including the ligation of intersphincteric fistula tract (LIFT) technique. Signum Surgical developed the BioHealx device, for improvement in surgical procedures to fulfil all identified essential clinical requirements for reliable healing of heal anal fistulas.

Research Methodology

The market study of the global anal fistula therapeutics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Anal Fistula Therapeutics Market Research and Analysis by Treatment
  • Global Anal Fistula Therapeutics Market Research and Analysis by Application
  • Global Anal Fistula Therapeutics Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global anal fistula therapeutics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global anal fistula therapeutics market.
  • Insights about market determinants, which are stimulating the global anal fistula therapeutics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules and Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Medtronic plc
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Karl Storz SE & Co. KG
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Cook Group Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Takeda Pharmaceutical Co. Ltd.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Signum Surgical Ltd.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Anal Fistula Therapeutics Market by Treatment
    • 5.1.1. Surgical
    • 5.1.2. Non-Surgical
  • 5.2. Global Anal Fistula Therapeutics Market by Application
    • 5.2.1. Intersphincteric Fistula
    • 5.2.2. Transsphincteric Fistula
    • 5.2.3. Suprasphincteric Fistula
    • 5.2.4. Others
  • 5.3. Global Anal Fistula Therapeutics Market by End-User
    • 5.3.1. Hospitals
    • 5.3.2. Ambulatory Surgical Centers
    • 5.3.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Medtronic plc
  • 7.2. Cook Group Inc.
  • 7.3. Takeda Pharmaceutical Co. Ltd.
  • 7.4. Karl Storz SE & Co. KG
  • 7.5. Biolitec AG
  • 7.6. Pfizer Inc.
  • 7.7. Becton, Dickinson and Co.
  • 7.8. GEM S.r.l.
  • 7.9. TiGenix NV
  • 7.10. W. L. Gore & Associates, Inc.
  • 7.11. AstraZeneca plc
  • 7.12. Agency for Medical Innovations (A.M.I.) GmbH
  • 7.13. Signum Surgical Ltd.
  • 7.14. Novartis International AG
  • 7.15. Assembly Biosciences, Inc.
  • 7.16. Ovesco Endoscopy AG

LIST OF TABLES

  • 1. GLOBAL ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2019-2026 ($ MILLION)
  • 2. GLOBAL SURGICAL ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL NON-SURGICAL ANAL FISTULA THERAPEUTICS DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 5. GLOBAL INTERSPHINCTERIC FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL TRANSSPHINCTERIC FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL SUPRASPHINCTERIC FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 8. GLOBAL OTHER ANAL FISTULA THERAPEUTICS APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL ANAL FISTULA THERAPEUTICS IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 10. GLOBAL ANAL FISTULA THERAPEUTICS IN AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 11. GLOBAL ANAL FISTULA THERAPEUTICS IN OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 12. GLOBAL ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 13. NORTH AMERICAN ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 14. NORTH AMERICAN ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2019-2026 ($ MILLION)
  • 15. NORTH AMERICAN ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 16. NORTH AMERICAN ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 17. EUROPEAN ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 18. EUROPEAN ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2019-2026 ($ MILLION)
  • 19. EUROPEAN ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 20. EUROPEAN ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 21. ASIA-PACIFIC ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 22. ASIA-PACIFIC ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2019-2026 ($ MILLION)
  • 23. REST OF THE WORLD ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 24. REST OF THE WORLD ANAL FISTULA THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ANAL FISTULA THERAPEUTICS MARKET SHARE BY TREATMENT, 2019 VS 2026 (%)
  • 2. GLOBAL ANAL FISTULA THERAPEUTICS MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
  • 3. GLOBAL ANAL FISTULA THERAPEUTICS MARKET SHARE BY END-USER, 2019 VS 2026 (%)
  • 4. GLOBAL ANAL FISTULA THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 5. US ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. CANADA ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. UK ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. FRANCE ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. GERMANY ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ITALY ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. SPAIN ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. ROE ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. INDIA ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. CHINA ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. JAPAN ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 17. REST OF THE WORLD ANAL FISTULA THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)